Growth Hormone & Recovery Peptides
GH secretagogues and recovery peptides for endocrine signaling and regenerative research.
Research Overview
Growth hormone peptides are research compounds that modulate somatotropic signaling through growth hormone-releasing hormone (GHRH) receptor agonism, ghrelin receptor engagement, or downstream effectors of tissue repair. These research peptides are studied for their roles in pituitary GH secretion, IGF-1 axis activation, and regenerative cell migration in laboratory models. Selective GH secretagogues such as ipamorelin minimize cortisol and prolactin co-stimulation compared with broader-acting analogues, enabling cleaner pharmacological dissection. GHRH mimetics including tesamorelin and CJC-1295 variants activate GHRH receptors on somatotrophs, while thymosin beta-4 fragments support actin-binding and wound-healing pathway research. Investigators apply growth hormone peptides in endocrine cell lines, primary pituitary cultures, and tissue repair assays to characterize receptor selectivity, pulse dynamics, and cross-talk with metabolic incretin pathways.
Peptide Comparison
Primary research targets and mechanism summaries for leading compounds in this category.
| Peptide | Primary Research Target | Mechanism Summary | CAS |
|---|---|---|---|
| Tesamorelin growth hormone peptide | GHRH receptor | GHRH analogue stimulates somatotroph GH release via Gs-coupled receptor activation and cAMP elevation in endocrine research models. | 901758-09-6 |
| Ipamorelin growth hormone peptide | Ghrelin receptor (GHS-R1a) | Selective GH secretagogue promotes pituitary GH pulses with minimal impact on cortisol and prolactin in comparative endocrine assays. | 170851-70-4 |
| CJC-1295 Without DAC growth hormone peptide | GHRH receptor | Modified GHRH peptide stimulates GH axis signaling; studied for pulse amplitude and frequency in somatotropic pharmacology. | 863288-34-0 |
| TB-500 (Thymosin Beta-4) recovery peptide | Actin / cell migration pathways | Thymosin beta-4 fragment modulates actin polymerization and cellular migration in regenerative and recovery research models. | 77591-33-4 |
Growth Hormone Peptides Catalog
Tesamorelin – Growth Hormone Peptides
CAS: 901758-09-6
Purity: ≥98%
Browse Growth Hormone Peptides for ResearchTesamorelin growth hormone peptide →Ipamorelin – Growth Hormone Peptides
CAS: 170851-70-4
Purity: ≥98%
Browse Growth Hormone Peptides for ResearchIpamorelin growth hormone peptide →CJC-1295 Without DAC – Growth Hormone Peptides
CAS: 863288-34-0
Purity: ≥98%
Browse Growth Hormone Peptides for ResearchCJC-1295 Without DAC growth hormone peptide →HGH Fragment 176-191 – Growth Hormone Peptides
CAS: 66004-57-7
Purity: ≥98%
Browse Growth Hormone Peptides for ResearchHGH Fragment 176-191 growth hormone peptide →TB-500 (Thymosin Beta-4) – Growth Hormone Peptides
CAS: 77591-33-4
Purity: ≥98%
Browse Growth Hormone Peptides for ResearchTB-500 (Thymosin Beta-4) recovery peptide →Frequently Asked Questions
Research-focused answers for this peptide category. For laboratory use only — not medical advice.
- How do growth hormone peptides work in research models?
- Growth hormone peptides act through distinct receptor classes: GHRH analogues activate GHRH receptors on pituitary somatotrophs, while ghrelin-mimetic secretagogues engage GHS-R1a. Both pathways elevate intracellular cAMP or calcium signals that trigger GH vesicle release, with downstream IGF-1 production studied in hepatocyte and tissue co-culture systems.
- What is the difference between GHRH analogues and GH secretagogues?
- GHRH analogues such as tesamorelin mimic the native hypothalamic releasing hormone at the GHRH receptor. GH secretagogues like ipamorelin act through the ghrelin receptor to stimulate GH release via a separate hypothalamic–pituitary input. Comparative research uses both classes to dissociate receptor-specific effects on pulse dynamics.
- Are growth hormone peptides studied for tissue repair research?
- Yes. Thymosin beta-4 fragments and related recovery peptides are investigated for actin cytoskeleton modulation, endothelial cell migration, and extracellular matrix remodeling in wound-healing and regenerative assays, distinct from classical GH secretagogue pharmacology.
- How does the growth hormone axis interact with GLP-1 metabolic peptide research?
- Somatotropic and incretin pathways converge on insulin sensitivity, lipolysis, and body composition endpoints in rodent models. Researchers co-characterize GH secretagogue and GLP-1 agonist signaling to map endocrine cross-talk in metabolic–endocrine interaction studies.
- What receptors are primary targets for growth hormone research peptides?
- Primary targets include the GHRH receptor, ghrelin receptor (GHS-R1a), and downstream GH receptor on peripheral tissues. Recovery-oriented peptides in this category may additionally engage cytoskeletal and cell migration pathways rather than classical pituitary receptors.
Related Research Areas
Explore adjacent peptide categories, key compounds, and cross-disciplinary research topics.
- GLP-1 metabolic peptide research overview
- Regenerative signaling peptide research catalog
- Cognitive neuropeptide mechanism research
- Dermatological anti-aging peptide studies
- Tesamorelin GHRH receptor agonist research profile
- Ipamorelin selective GH secretagogue pharmacology
- TB-500 thymosin beta-4 tissue migration research
- BPC-157 regenerative pentadecapeptide studies
- Complete research peptides catalog